澳门太阳游戏城app官网入口

资源 » 参考数据库 » 客户发表文献

至今，GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次，处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果，再次证明GenScript 有能力帮助业内科学家Make research easy.

Correction: Development of oligonucleotide-based antagonists of Ebola virus protein 24 inhibiting its interaction with karyopherin alpha 1.

Org. Biomol. Chem.. 2018-10; 
TanakaKeisuke，KasaharaYuuya，MiyamotoYoichi，OkudaTakumi，KasaiTatsuro，OnoderaKentaro，KuwaharaMasayasu，OkaMasahiro，YonedaYoshihiro，ObikaSat
Products/Services Used Details Operation
Gene Synthesis … Preparation of recombinant eVP24 and FLAG-KPNA1. Plasmid construction. Full-length cDNA encoding eVP24 (KC242801) was synthesised and subcloned into the pUC57 plasmid vector by Genscript (Piscataway, NJ, USA) … Get A Quote

摘要

Correction for 'Development of oligonucleotide-based antagonists of Ebola virus protein 24 inhibiting its interaction with karyopherin alpha 1' by Keisuke Tanaka et al.， Org. Biomol. Chem.， 2018， 16， 4456-4463.

关键词

Article Link >